Activation of Rho GTPases in SmithLemliOpitz syndrome: pathophysiological and clinical implications

By Jiang Xiao-Sheng   Wassif Christopher A.   Backlund Peter S.   Song Li   Holtzclaw Lynne A.   Li Zheng   Yergey Alfred L.   Porter Forbes D.  

Human Molecular Genetics, Vol. 19, Iss. 7, 2010-04 ,pp. : 1347-1357

Oxford University Press

Access to resources Recommend Favorite

Mutational Spectrum of Smith-Lemli-Opitz Syndrome Patients in Hungary

By  

Molecular Syndromology, Vol. 3, Iss. 5, 2012-11 ,pp. : 215-222

Karger

Access to resources Recommend Favorite

Spontaneously regressing brain lesions in Smith–Lemli–Opitz syndrome

By  

American Journal Of Medical Genetics Part A, Vol. 176, Iss. 2, 2018-02 ,pp. : 386-390

John Wiley & Sons Inc

Access to resources Recommend Favorite

Development and characterization of a hypomorphic Smith–Lemli–Opitz syndrome mouse model and efficacy of simvastatin therapy

By Correa-Cerro Lina S.   Wassif Christopher A.   Kratz Lisa   Miller Georgina F.   Munasinghe Jeeva P.   Grinberg Alexander   Fliesler Steven J.   Porter Forbes D.  

Human Molecular Genetics, Vol. 15, Iss. 6, 2006-03 ,pp. : 839-851

Oxford University Press

Access to resources Recommend Favorite

Biochemical, phenotypic and neurophysiological characterization of a genetic mouse model of RSH/Smith–Lemli–Opitz syndrome

By Kelley R.I.  

Human Molecular Genetics, Vol. 10, Iss. 6, 2001-03 ,pp. : 555-564

Oxford University Press

Access to resources Recommend Favorite